Hormonal perturbation as a possible mechanism for the alteration of cytochrome P450 by cyclophosphamideMCCLURE, M. T; STUPANS, I.Biochemical pharmacology. 1995, Vol 49, Num 12, pp 1827-1836, issn 0006-2952Article

The inhibition of drug oxidation by anhydroerythromycin, an acid degradation product of erythromycinSTUPANS, I; SANSOM, L. N.Biochemical pharmacology. 1991, Vol 42, Num 11, pp 2085-2090, issn 0006-2952Article

Investigation of the mechanism by which cyclophosphamide alters cytochrome P450 in male ratsMCCLURE, M. T; STUPANS, I.Biochemical pharmacology. 1992, Vol 43, Num 12, pp 2655-2658, issn 0006-2952Article

Cyclophosphamide administered repeatedly to the male rat and as a single dose to the female rat. Its effects on hepatic and pulmonary P450 and associated enzymesANGLEY, M. T; SANSOM, L. N; STUPANS, I et al.Xenobiotica (London. Print). 1995, Vol 25, Num 10, pp 1051-1062, issn 0049-8254Article

Influence of morphine concentration on detergent activation of rat liver morphine-UDP-glucuronosyltransferaseLEAR, L; NATION, R. L; STUPANS, I et al.Biochemical pharmacology. 1991, Vol 42, pp S55-S60, issn 0006-2952, SUPArticle

Microsomal metabolism and enzyme kinetics of the terpene p-cymene in the common brushtail possum (Trichosurus vulpecula), koala (Phascolarctos cinereus) and ratPASS, G. J; MCLEAN, S; STUPANS, I et al.Xenobiotica (London. Print). 2002, Vol 32, Num 5, pp 383-397, issn 0049-8254Article

Microsomal metabolism of the terpene 1,8-cineole in the common brushtail possum (Trichosurus vulpecula), koala (Phascolarctos cinereus), rat and humanPASS, G. J; MCLEAN, S; STUPANS, I et al.Xenobiotica (London. Print). 2001, Vol 31, Num 4, pp 205-221, issn 0049-8254Article

Specificity of rabbit cytochrome P-450 isozymes involved in the metabolic activation of the food derived mutagen 2-amino-3-methylimidazo[4,5-f] quinolineMCMANUS, M. E; BURGESS, W; SNYDERWINE, E et al.Cancer research (Baltimore). 1988, Vol 48, Num 16, pp 4513-4519, issn 0008-5472Article

Immunohistochemical localization of NADPH-cytochrome P450 reductase in human tissuesHALL, P. DE LA M; STUPANS, I; BURGESS, W et al.Carcinogenesis (New York. Print). 1989, Vol 10, Num 3, pp 521-530, issn 0143-3334Article

Theophylline metabolism by human, rabbit and rat liver microsomes and by purified forms of cytochrome P450MCMANUS, M. E; MINERS, J. O; GREGOR, D et al.Journal of pharmacy and pharmacology. 1988, Vol 40, Num 6, pp 388-391, issn 0022-3573Article

Immunohistochemical localization and quantitation of NADPH-cytochrome P-450 reductase in human liverMCMANUS, M. E; HALL, P. DE LA M; STUPANS, I et al.Molecular pharmacology. 1987, Vol 32, Num 2, pp 189-194, issn 0026-895XArticle

Effect of dexamethasone on cytochrome P-450 mediated metabolism of 2-acetylaminofluorene in cultured rat hepatocytesMCMANUS, M. E; EDWARDS, A. M; STUPANS, I et al.Biochemical pharmacology. 1987, Vol 36, Num 2, pp 237-243, issn 0006-2952Article

Flavin-containing monooxygenase activity in human liver microsomesMCMANUS, M. E; STUPANS, I; BURGESS, W et al.Drug metabolism and disposition. 1987, Vol 15, Num 2, pp 256-261, issn 0090-9556Article

Characterization of theophylline metabolism by human liver microsomes: inhibition and immunpchemical studiesROBSON, R. A; MINERS, J. O; MATTHEWS, A. P et al.Biochemical pharmacology. 1988, Vol 37, Num 9, pp 1651-1659, issn 0006-2952Article

Activation of the food-derived mutagen 2-amino-3-methylimidazo[4,5-f]quinoline by human-liver microsomesMCMANUS, M. E; BURGESS, W; STUPANS, I et al.Mutation research. 1988, Vol 204, Num 2, pp 185-193, issn 0027-5107Article